P-128. Regulation of vascular endothelial growth factor expression in human endometrium by steroids: in-vitro and in-vivo studies

In: Human Reproduction · 1997 · vol. 12(Suppl_2) , pp. 180–181 · doi:10.1093/humrep/12.suppl_2.180-b · W2587849008
article OA: bronze CC0
📄 Open PDF View on OpenAlex View at publisher
AI-generated summary by claude@2026-06, 2026-06-08

Steroid treatment of human endometrium in vitro and in vivo altered vascular endothelial growth factor expression, with RU486 significantly increasing it in Norplant-treated endometrium.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Abstracts of the 13th Annual Meeting of the ESHRE, Edinburgh 1997 significantly increased (P < 0.05) in Norplant-treated endometrium following RU486 administration.Conclusion: Endometrium exposed to Norplant® and antiprogestogen displayed a significant increase in glandular ER concentration and all biopsies showed proliferative histology, consistent with endometrial regeneration.The regular (probably monthly) administration of an anti-progesterone may improve bleeding patterns among Norplant users.Because it induces ovulation, the contraceptive efficacy of Norplant may be reduced but a larger scale efficacy study is required.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK